The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Despite the large number of patients and anticoagulant treatment standardization, the Ottawa score failed to accurately predict recurrent VTE in patients with CAT treated with tinzaparin.
Authors
- Olivier Sanchez (ORCID: https://orcid.org/0000-0003-1633-8391)
- Philippe Girard (ORCID: https://orcid.org/0000-0002-1559-8055)
- Isabelle Mahé (ORCID: https://orcid.org/0000-0003-1760-7880)
- Patrick Mismetti (ORCID: https://orcid.org/0000-0003-1511-0555)
- Céline Chapelle (ORCID: https://orcid.org/0000-0003-3281-3666)
- Alvin Lee (ORCID: https://orcid.org/0000-0002-7427-9142)
- Géraldine Poénou (ORCID: https://orcid.org/0000-0001-8020-9215)
- Luis Jara‐Palomares (ORCID: https://orcid.org/0000-0002-4125-3376)
- Silvy Laporte
- Guy Meyer
Institutions
- University of British Columbia (CA)
- Inserm (FR)
- Université Paris Cité (FR)
- Instituto de Salud Carlos III (ES)
- Hôpital Louis-Mourier (FR)
- Institute Mutualiste Montsouris (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
- Hôpital Nord (FR)
- Paris Cardiovascular Research Center (FR)
- Hospital Universitario Virgen del Rocío (ES)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
- French Clinical Research Infrastructure Network (FR)
- Université Jean Monnet (FR)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.rpth.2025.103278
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00